Effects of su‐13437, a new hypolipidemic drug, upon synthesis in vivo of hepatic and carcass total fatty acids and total cholesterol

This publication has 14 references indexed in Scilit:

• Effect of a hypolipidaemic drug (CH 13,437) on plasma and tissue lipids, and on the intravenous fat tolerance in man
  Atherosclerosis, 1970
• Clinical evaluation of a new hypolipidemic drug, CIBA 13,437-Su
  Journal of Atherosclerosis Research, 1969
• Differences between the metabolism of linoleic and palmitic acid: Utilization for cholesterol synthesis and oxidation to respiratory CO₂
  Lipids, 1969
• Biochemical changes in rat liver in response to treatment with drugs and other agents—I: Effects of anticonvulsant, anti-inflammatory, hypocholesterolaemic and adrenergic β-blocking agents
  Biochemical Pharmacology, 1969
• Evaluation of Phenolic Ethers as Hypolipidaemic Agents: Effects of CIBA 13,437-SU
  Published by Springer Nature ,1969
• Hypolipidaemic properties of a new tetralin derivative (CIBA 13,437-Su)
  Cellular and Molecular Life Sciences, 1968
• Effects of chlorophenoxyisobutyrate (CPIB) on liver composition and triglyceride synthesis in rats
  Journal of Atherosclerosis Research, 1966
• Studies with ethyl chlorophenoxyisobutyrate (clofibrate)
  Metabolism, 1965
• EFFECTS OF ALPHA-P-CHLOROPHENOXYISOBUTYRYL ETHYL ESTER (CPIB) WITH AND WITHOUT ANDROSTERONE ON CHOLESTEROL BIOSYNTHESIS IN RAT LIVER
  1965
• A semiautomated procedure for the determination of triglycerides in serum
  Analytical Biochemistry, 1964